Ginkgo Bioworks Holdings, Inc. (DNA) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $508.59M | -29.0% |
| 2024 | $716.06M | -34.7% |
| 2023 | $1.10B | -36.8% |
| 2022 | $1.74B | +15.3% |
| 2021 | $1.51B | +226.3% |
| 2020 | $461.38M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $508.59M | -29.0% |
| 2024 | $716.06M | -34.7% |
| 2023 | $1.10B | -36.8% |
| 2022 | $1.74B | +15.3% |
| 2021 | $1.51B | +226.3% |
| 2020 | $461.38M | — |